Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-25

FDA Approved: ZEMDRI (PLAZOMICIN) — Original Application (Cipla Therapeutics Inc.)

View source ↗

Summary

FDA approved ZemdrI (plazomicin) under an original NDA from Cipla Therapeutics Inc. as a new antibiotic for complicated urinary tract infections including pyelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZEMDRI (plazomicin)

Snippet

ORIG AP for ZEMDRI (PLAZOMICIN) (PLAZOMICIN)